Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Biotechnology

Healthcare
$39.15 +8.79%

+$2.32 today

Market cap
$1.83B
Beta
0.00
52W Low $23.00High $36.61

Volume 0.30M

Average 0.34M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$70.12M

FY 2025 · Annual

Net Income

-$63.91M

FY 2025 · Annual

COAG Earnings Waterfall · TTM

NASDAQ:COAG · Revenue to Net Income

No earnings data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
4Statement of changes in beneficial ownershipSep 25, 2026
3Initial statement of beneficial ownershipSep 25, 2026

How much revenue does COAG generate?

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) reported $0.00 of revenue in fiscal 2025.

Is COAG profitable?

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) reported -$63.91M of net income.